SciVision Biotech Reports 2Q Net Profit of NT$34.6M
SciVision Biotech reported second-quarter net profit of NT$34.6 million, compared with a net loss of NT$16.0 million a year earlier. Revenue was NT$211.026 million versus NT$209.487 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.